Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Annual Meeting 2019

Annual Meeting Materials

The annual meeting of shareholders will be held:

Tuesday, May 21st 2019, 8:00 a.m.
Cooley LLP
500 Boylston Street
Boston, Massachusetts 02116

Before you vote, you should carefully review our 2019 Proxy Statement, Form 10-K for fiscal year 2018, 2018 Annual Report, and related materials that were mailed on or around April 4, 2019, to shareholders of record as of March 22, 2019. For your convenience, these materials may be viewed by selecting the links below:

To view the Proxy Statement or Form 10-K, you will need Adobe Acrobat; click here for detailed download instructions.

Related Links

Corporate Governance  | SEC Filings  | Contact Information

Stock Quote

CRL (common)
Price
$129.41
Change (%)
- 2.56 (1.94%)
Volume
285,623
Exchange
NYSE
Data as of 06/14/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)